SINTX TechnologiesSINT -2.07%27 Return-on-Tangible-Equity is -763.98% as of Mar. 2026. GuruFocus rates SINT with a GF Score™ of 27/100 and a GF Value™ of $0.15 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 758 Medical Devices & Instruments companies, SINTX Technologies ranks worse than 96.04% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. SINTX Technologies's annualized net income for the quarter that ended in Mar. 2026 was $-11.28 Mil. SINTX Technologies's average shareholder tangible equity for the quarter that ended in Mar. 2026 was $1.48 Mil. Therefore, SINTX Technologies's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was -763.98%.
The historical rank and industry rank for SINTX Technologies's Return-on-Tangible-Equity or its related term are showing as below:
SINT'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -1602.92 Med: -144.53 Max: -43.37
Current: -327.69
During the past 13 years, SINTX Technologies's highest Return-on-Tangible-Equity was -43.37%. The lowest was -1,602.92%. And the median was -144.53%.
SINT's Return-on-Tangible-Equity is ranked worse than 96.04% of 758
companies
in the Medical Devices & Instruments industry
Industry Median: 4.08
vs SINT: -327.69
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
SINTX Technologies Return-on-Tangible-Equity Related Terms
SINTX Technologies Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for SINTX Technologies's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SINT vs ALRTF, CODX, PMI: Return-on-Tangible-Equity Comparison
For the Medical Devices subindustry, SINTX Technologies's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SINTX Technologies Return-on-Tangible-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SINTX Technologies's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where SINTX Technologies's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of -763.98% mean?
SINTX Technologies (SINT) has a Return-on-Tangible-Equity of -763.98% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on SINTX Technologies and its competitors. According to the industry distribution chart, SINTX Technologies ranks #728 out of 758 companies in the Medical Devices & Instruments industry, placing it in the top 96%.
Is SINTX Technologies' Return-on-Tangible-Equity too high?
SINTX Technologies' current Return-on-Tangible-Equity is -763.98%. Based on the distribution chart, SINTX Technologies ranks #728 out of 758 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, SINTX Technologies has a GF Score™ of 27/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SINTX Technologies' Return-on-Tangible-Equity compare to ALRTF and CODX?
According to the Medical Devices & Instruments industry distribution chart, SINTX Technologies ranks #728 out of 758 companies for Return-on-Tangible-Equity. This places SINTX Technologies in the lower half of its industry. The industry median Return-on-Tangible-Equity is 4.08. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Devices & Instruments company?
The median Return-on-Tangible-Equity among Medical Devices & Instruments companies is 4.08, based on 758 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on SINTX Technologies and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Equity is 4.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SINTX Technologies's current Return-on-Tangible-Equity is -763.98%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SINTX Technologies stock overvalued right now?
Based on GuruFocus' analysis, SINTX Technologies (SINT) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.15, compared to a current price of $1.89 — trading 1160% above its estimated fair value. The current Return-on-Tangible-Equity is -763.98%. SINTX Technologies' overall GF Score™ is 27/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For SINTX Technologies (SINT), the current Return-on-Tangible-Equity is -763.98% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SINTX Technologies (SINT) Overvalued in 2026?
Based on GuruFocus' analysis, SINTX Technologies stock appears to be overvalued.
The current stock price of $1.89 is trading 1160% above its estimated GF Value™ of $0.15.
GuruFocus considers SINTX Technologies to be Significantly Overvalued.
Key valuation signals for SINT:
Return-on-Tangible-Equity: -763.98%
GF Value™: $0.15 vs. price of $1.89 (1160% above fair value)
No single metric tells the full story. See the SINT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SINTX Technologies Inc is an advance ceramics company that develops, manufactures, and commercializes silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications. It provides biomedical solutions for medical devices specializing in silicon nitride (Si3N4) for musculoskeletal and antipathogenic applications. It also manufactures silicon nitride parts for customers in the electrical, aerospace, and other industrial sectors. The company is a globalised leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans. The Company operates as one operating segment.
27GF Score
Get the complete analysis for SINT
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SINT has been successfully added to your 
